Hjem
Per Sigvald Bakkes bilde

Per Sigvald Bakke

Dekan, Det medisinske fakultet
  • E-postPer.Bakke@uib.no
  • Telefon+47 55 58 20 87+47 992 04 032
  • Besøksadresse
    Armauer Hansens Hus
    Haukelandsveien 28
    Rom 
    407, 4. etasje
  • Postadresse
    Postboks 7804
    5020 BERGEN
Vitenskapelig artikkel
  • Vis forfatter(e) (2019). Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma. Respiratory Medicine. 66-73.
  • Vis forfatter(e) (2019). Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLOS ONE. 1-18.
  • Vis forfatter(e) (2019). Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. The International Journal of Chronic Obstructive Pulmonary Disease. 1639-1655.
  • Vis forfatter(e) (2019). Comparison of two lung cancer screening scores among patients with chronic obstructive pulmonary disease: A community study. Clinical Respiratory Journal. 114-119.
  • Vis forfatter(e) (2018). Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: An exploratory analysis. European Respiratory Journal.
  • Vis forfatter(e) (2018). Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers. Metabolomics. 1-12.
  • Vis forfatter(e) (2018). Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease. BMC Medicine. 1-13.
  • Vis forfatter(e) (2018). Integration of Molecular Interactome and Targeted Interaction Analysis to Identify a COPD Disease Network Module. Scientific Reports. 1-14.
  • Vis forfatter(e) (2018). Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk . Nature Communications. 1-15.
  • Vis forfatter(e) (2018). Guideline adherence in hospital recruited and population based COPD patients. BMC Pulmonary Medicine. 1-9.
  • Vis forfatter(e) (2018). Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort. PLOS ONE. 1-16.
  • Vis forfatter(e) (2018). Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort. Respiratory Medicine. 14-19.
  • Vis forfatter(e) (2017). Variable susceptibility to cigarette smoke-induced emphysema in 34 inbred strains of mice implicates Abi3bp in emphysema susceptibility. American Journal of Respiratory Cell and Molecular Biology. 367-375.
  • Vis forfatter(e) (2017). U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. Journal of Allergy and Clinical Immunology. 1797-1807.
  • Vis forfatter(e) (2017). Sex-based genetic association study identifies celsr1 as a possible chronic obstructive pulmonary disease risk locus among women. American Journal of Respiratory Cell and Molecular Biology. 332-341.
  • Vis forfatter(e) (2017). Randomised comparison of needle aspiration and chest tube drainage in spontaneous pneumothorax. European Respiratory Journal. 1-9.
  • Vis forfatter(e) (2017). Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma. Human Molecular Genetics. 1584-1596.
  • Vis forfatter(e) (2017). Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nature Genetics. 1126-1132.
  • Vis forfatter(e) (2017). Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: A community-based cohort. European Respiratory Journal. 1-8.
  • Vis forfatter(e) (2017). Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis. 336-346.
  • Vis forfatter(e) (2017). Genome-wide association study of the genetic determinants of emphysema distribution. American Journal of Respiratory and Critical Care Medicine. 757-771.
  • Vis forfatter(e) (2017). Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nature Genetics. 416-425.
  • Vis forfatter(e) (2017). Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nature Genetics. 426-432.
  • Vis forfatter(e) (2017). Genetic association and risk scores in a chronic obstructive pulmonary disease meta-analysis of 16,707 subjects. American Journal of Respiratory Cell and Molecular Biology. 35-46.
  • Vis forfatter(e) (2017). A simple algorithm for the identification of clinical COPD phenotypes. European Respiratory Journal. 1-11.
  • Vis forfatter(e) (2016). Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study. Respiratory Research. 1-21.
  • Vis forfatter(e) (2016). Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. Respiratory Medicine. 53-59.
  • Vis forfatter(e) (2016). Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD patients. European Respiratory Journal. 82-91.
  • Vis forfatter(e) (2016). Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer. BMC Cancer.
  • Vis forfatter(e) (2016). Macrophage migration inhibitory factor, a role in COPD. American Journal of Physiology - Lung cellular and Molecular Physiology. L1-L7.
  • Vis forfatter(e) (2016). Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. The International Journal of Chronic Obstructive Pulmonary Disease. 2099-2108.
  • Vis forfatter(e) (2016). Global lung function initiative 2012 reference equations for spirometry in the Norwegian population. European Respiratory Journal. 1602-1611.
  • Vis forfatter(e) (2016). Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study. Respiratory Medicine. 87-95.
  • Vis forfatter(e) (2016). A genome-wide analysis of the response to inhaled β 2-agonists in chronic obstructive pulmonary disease. The Pharmacogenomics Journal. 326-335.
  • Vis forfatter(e) (2015). Variability of within-breath reactance in COPD patients and its association with dyspnoea. European Respiratory Journal. 625-634.
  • Vis forfatter(e) (2015). The relationship of educational attainment with pulmonary emphysema and airway wall thickness. Annals of the American Thoracic Society. 813-820.
  • Vis forfatter(e) (2015). Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. Respiratory Medicine. 1138-1146.
  • Vis forfatter(e) (2015). Pneumothorax size measurements on digital chest radiographs: Intra- and inter- rater reliability. European Journal of Radiology. 2038-2043.
  • Vis forfatter(e) (2015). Peak oxygen uptake and breathing pattern in COPD patients - a four-year longitudinal study. BMC Pulmonary Medicine.
  • Vis forfatter(e) (2015). One-year change in health status and subsequent outcomes in COPD. Thorax. 420-425.
  • Vis forfatter(e) (2015). A genome-wide association study of emphysema and airway quantitative imaging phenotypes. American Journal of Respiratory and Critical Care Medicine. 559-569.
  • Vis forfatter(e) (2014). DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease. Respiratory Research.
  • Vis forfatter(e) (2014). Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 718-723.
  • Vis forfatter(e) (2013). Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease. BMC Pulmonary Medicine. 10 sider.
  • Vis forfatter(e) (2013). Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. Respiratory Medicine. 1201-1209.
  • Vis forfatter(e) (2013). Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes? Annals of Nutrition and Metabolism. 239-247.
  • Vis forfatter(e) (2012). Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. COPD: Journal of Chronic Obstructive Pulmonary Disease. 227-234.
  • Vis forfatter(e) (2012). Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLOS ONE. 8 sider.
  • Vis forfatter(e) (2012). Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults. Respirology (Carlton South. Print). 499-505.
  • Vis forfatter(e) (2009). Quantitative CT Measures of Emphysema and Airway Wall Thickness Are Related to Respiratory Symptoms. American Journal of Respiratory and Critical Care Medicine.
  • Vis forfatter(e) (2009). Prevalens av hjemmerespiratorbehandling i Norge. Tidsskrift for Den norske legeforening. 2094-2097.
  • Vis forfatter(e) (2009). Occupational exposure and incidence of respiratory disorders in a general population. Scandinavian Journal of Work, Environment and Health. 454-460.
  • Vis forfatter(e) (2008). Clinical data discriminating between adults with positive and negative results on bronchodilator testing. The International Journal of Tuberculosis and Lung Disease. 205-213.
  • Vis forfatter(e) (2007). Feasible and simple exclusion criteria for pulmonary reference populations. Thorax. 792-798.
  • Vis forfatter(e) (2006). Post-bronchodilator spirometry reference values in adults and implications for disease management. American Journal of Respiratory and Critical Care Medicine. 1316-1325.
  • Vis forfatter(e) (2006). Opplæring av pasienter i riktig bruk av inhalasjonsmedisiner. Tidsskrift for Den norske legeforening. 312-314.
  • Vis forfatter(e) (2006). Obstruktiv lungesykdom hos barn og voksne. Presentasjon av et integrert undervisningsopplegg i allmennmedisin. UNIPED. 24-30.
  • Vis forfatter(e) (2006). Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta(2)-agonist. Pulmonary Pharmacology & Therapeutics. 272-280.
  • Vis forfatter(e) (2005). The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood. American Journal of Respiratory and Critical Care Medicine. 61-66.
  • Vis forfatter(e) (2005). Scandinavian COPD research symposium. Respiratory Medicine.
  • Vis forfatter(e) (2005). Røykevaner blant medisinstudenter i Bergen. Tidsskrift for Den norske legeforening. 276-277.
  • Vis forfatter(e) (2005). Predictors of smoking cessation in patients admitted for acute coronary heart disease. Journal of Cardiovascular Risk. 472-477.
  • Vis forfatter(e) (2005). Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. The International Journal of Tuberculosis and Lung Disease. 926-932.
  • Vis forfatter(e) (2005). Et tverrfaglig undervisningsopplegg om obstruktiv lungesykdom i allmennpraksis. Tidsskrift for Den norske legeforening. 465-465.
  • Vis forfatter(e) (2005). Assessment of lung volumes in children and adolescents: comparison of two plethysmographic techniques. Clinical Physiology and Functional Imaging. 62-68.
  • Vis forfatter(e) (2004). Trends in symptoms of obstructive lung disease in Norway. The International Journal of Tuberculosis and Lung Disease. 1416-1422.
  • Vis forfatter(e) (2004). Trends in symptoms of obstructive lung disease in Norway. The International Journal of Tuberculosis and Lung Disease. 1416-1422.
  • Vis forfatter(e) (2004). The effect of educational level on the incidence of asthma and respiratory symptoms. Respiratory Medicine. 730-736.
  • Vis forfatter(e) (2004). Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. European Respiratory Journal. 589-594.
  • Vis forfatter(e) (2004). Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatrica. 1294-1300.
  • Vis forfatter(e) (2004). Pulmonary gas exchange and educational level: a community study. European Respiratory Journal. 583-588.
  • Vis forfatter(e) (2004). Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. Scandinavian Journal of Public Health. 411-417.
  • Vis forfatter(e) (2004). Interpreting and reporting results. The International Journal of Tuberculosis and Lung Disease. 1506-1509.
  • Vis forfatter(e) (2004). Bias in retrospective studies of trends in asthma incidence. European Respiratory Journal. 281-286.
  • Vis forfatter(e) (2004). Atopic and non-atopic asthma in a farming and a general population. American Journal of Industrial Medicine. 396-399.
  • Vis forfatter(e) (2003). Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. Scandinavian Journal of Public Health. 1-7.
  • Vis forfatter(e) (2003). Long-term changes in adult asthma prevalence. European Respiratory Journal. 468-472.
  • Vis forfatter(e) (2003). Factors affecting growth of FEV1. Monaldi Archives for Chest Disease. 103-107.
  • Vis forfatter(e) (2003). Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. European Respiratory Journal. 3s-9s.
  • Vis forfatter(e) (2003). Does smoking affect the outcome of patient education and self-management in asthmatics? Patient Education and Counseling. 91-97.
  • Vis forfatter(e) (2003). Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. American Journal of Epidemiology. 558-566.
  • Vis forfatter(e) (2002). Occupational airborne exposure and the incidence of respiratory symptoms and asthma. American Journal of Respiratory and Critical Care Medicine. 933-938.
  • Vis forfatter(e) (2002). Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. Journal of Clinical Epidemiology. 775-781.
  • Vis forfatter(e) (2002). Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. European Respiratory Journal. 599-605.
  • Vis forfatter(e) (2002). Effekter av astmaopplæring i en randomisert, kontrollert undersøkelse. Tidsskrift for Den norske legeforening. 2702-2706.
  • Vis forfatter(e) (2002). Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial. Respiratory Medicine. 424-431.
  • Vis forfatter(e) (2002). Comparison of telephone and postal survey modes on respiratory symptoms and risk factors. American Journal of Epidemiology. 572-576.
  • Vis forfatter(e) (2001). Standardized submaximal exercise testing in never smokers: A normative study. Clinical Physiology and Functional Imaging. 629-636.
  • Vis forfatter(e) (2001). Relationship of occupational exposure to respiratory symptoms and asthma in a general population sample – self-reported versus interview based exposure data. American Journal of Epidemiology. 477-483.
  • Vis forfatter(e) (2001). Relationship between occupational exposure, estimated by two job-exposure matrices, and lung function in French, Dutch, and Norwegian community studies. European Respiratory Review. 91-97.
  • Vis forfatter(e) (2001). Increased circulating levels of alpha-1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs. European Respiratory Journal. 1105-1111.
  • Vis forfatter(e) (2001). Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. Clinical Physiology and Functional Imaging. 648-660.
  • Vis forfatter(e) (2001). Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial. European Respiratory Journal. 206-213.
  • Vis forfatter(e) (2001). Bronchitic symptoms and their relation to FEV1 in Italy, Sweden and Norway. European Respiratory Review. 74-79.
  • Vis forfatter(e) (2000). Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. The International Journal of Tuberculosis and Lung Disease. 649-656.
  • Vis forfatter(e) (2000). Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. The International Journal of Tuberculosis and Lung Disease. 649-656.
  • Vis forfatter(e) (2000). Study design. European Respiratory Monograph. 128-153.
  • Vis forfatter(e) (2000). Snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 1616-1621.
  • Vis forfatter(e) (2000). Snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 1616-1621.
  • Vis forfatter(e) (2000). Smoking status, disease duration, and educational level in females, are related to asthma school participation. European Respiratory Journal. 1022-1025.
  • Vis forfatter(e) (2000). Smoking status, disease duration, and educational level in females, are related to asthma school participation. European Respiratory Journal. 1022-1025.
  • Vis forfatter(e) (2000). Prevention of death from asthma. International Review of Asthma. 50-58.
  • Vis forfatter(e) (2000). Prevention of death from asthma. International Review of Asthma. 50-58.
  • Vis forfatter(e) (2000). Performance of population-specific job exposure-matrices (JEM). Occupational and Environmental Medicine. 126-132.
  • Vis forfatter(e) (2000). Performance of population-specific Job exposure-matrices (JEM). Occup Environ Med. 126-132.
  • Vis forfatter(e) (2000). Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. Respiratory Medicine. 1057-1064.
  • Vis forfatter(e) (2000). Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. Respiratory Medicine. 279-287.
  • Vis forfatter(e) (2000). Obstructive lung disease in patients within the hospital in the Nordic countries. European Respiratory Review. 428-431.
  • Vis forfatter(e) (2000). Obstructive lung disease in patients within the hospital in the Nordic countries. European Respiratory Review. 428-431.
  • Vis forfatter(e) (2000). Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. European Respiratory Review. 457-462.
  • Vis forfatter(e) (2000). Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. European Respiratory Review. 457-462.
  • Vis forfatter(e) (2000). Nonpharmacological intervention in obstructive lung disease. European Respiratory Review. 391-392.
  • Vis forfatter(e) (2000). Nonpharmacological intervention in obstructive lung disease. European Respiratory Review. 391-392.
  • Vis forfatter(e) (2000). Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. Respiratory Medicine. 279-287.
  • Vis forfatter(e) (2000). Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. Respiratory Medicine. 279-287.
  • Vis forfatter(e) (2000). I hvor stor grad snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 1616-1621.
  • Vis forfatter(e) (2000). Et forsvarlig blikk på bupropion. Lungeforum. 113-115.
  • Vis forfatter(e) (2000). Et forsvarlig blikk på bupropion. Lungeforum. 113-115.
  • Vis forfatter(e) (2000). Comparison of respiratory symptoms questionnaires. The International Journal of Tuberculosis and Lung Disease. 83-90.
  • Vis forfatter(e) (2000). Comparison of respiratory symptoms questionaires. The International Journal of Tuberculosis and Lung Disease. 83-90.
  • Vis forfatter(e) (1999). The risks of snoring and day-time hypersomnolence in a general Norwegian population. American Journal of Respiratory and Critical Care Medicine. S:A562.
  • Vis forfatter(e) (1999). The association of sex, age and smoking to respiratory symptoms in a longitudinal study in western Norway. European Respiratory Journal. 19.
  • Vis forfatter(e) (1999). Reproducibility of indoor environment characteristics obtained in a walk through questionaire. A pilot study. Indoor Air: International Journal of Indoor Environment and Health. 26-32.
  • Vis forfatter(e) (1999). Relationship between two biological inflammatory markers and single-breath transfer factor for carbon monoxide (TLCO) in a general population sample. European Respiratory Journal. 133.
  • Vis forfatter(e) (1999). New epidemiological interpretations of the average attributable fraction from a game theoretical perspective. American Journal of Respiratory and Critical Care Medicine. S:A320.
  • Vis forfatter(e) (1999). Incidence and remission rates of respiratory symptoms by sex, age and smoking in a Norwegian community during twelve years. American Journal of Respiratory and Critical Care Medicine. S:A134.
  • Vis forfatter(e) (1999). Decreasing response to respiratory disease surveys. Norwegian Respiratory Journal. 12.
  • Vis forfatter(e) (1999). Comparison between two respiratory symptomquestionnaires, by sex and smoking habits. American Journal of Respiratory and Critical Care Medicine. S:A134.
  • Vis forfatter(e) (1999). Asthma and wheezing are increasing in repeated community surveys of adults. European Respiratory Journal. 216.
  • Vis forfatter(e) (1999). Acute hospital treatment of obstructive lung disease in western Norway. Norwegian Respiratory Journal. 39.
  • Vis forfatter(e) (1998). Smokers, highly educated women and stable asthmatics do not want to participate in an asthma school. European Respiratory Journal. 404-404.
  • Vis forfatter(e) (1998). Serum inflammatory markers and level of carbon monoxide diffusion capacity in a general population sample. American Journal of Respiratory and Critical Care Medicine.
  • Vis forfatter(e) (1998). Relationship between single-breath transfer factor for carbon monoxide (TLCO) and airflow obstruction. European Respiratory Journal. 52.
  • Vis forfatter(e) (1998). Medikamentvaner og kunnskap om egen sykdom blant pasienter med obstruktiv lungesykdom. Tidsskrift for Den norske legeforening. 2006-2010.
  • Vis forfatter(e) (1998). Immunoglobulin E, viral antibodies and obstructive lung disease in adults. The relation between antibody level in serum, lung function and non-specific bronchial reactivity. Tidsskrift for Den norske legeforening. 1542-1547.
  • Vis forfatter(e) (1998). Immunglobulin E, virusantistoffer og obstruktiv lungesykdom hos voksne. Forholdet mellom antistoffnivå i serum, lungefunksjon og uspesifikk bronkial reaktivitet. Tidsskrift for Den norske legeforening. 1542-1547.
  • Vis forfatter(e) (1998). Hvorfor øker forekomsten av astma i Norge? Lungeforum. 169-169.
  • Vis forfatter(e) (1998). Applicability of the single breath carbon monoxide diffusing capacity in a Norwegian community study. American Journal of Respiratory and Critical Care Medicine. 1745-1750.
  • Vis forfatter(e) (1997). Transcutaneous abdominal ultrasonography in the staging of lung cancer. Thorax. 276-280.
  • Vis forfatter(e) (1997). Smoking and ulcer perforation. Gut. 177-180.
  • Vis forfatter(e) (1997). Smoking and ulcer perforation. Gut. 177-180.
  • Vis forfatter(e) (1997). Astma og inneklima i Hordaland. AstmaAllergi. 37.
  • Vis forfatter(e) (1996). Serum respiratory virus antibodies: Predictor of reduced one second forced expiratory volume in Norwegian adults. International Journal of Epidemiology. 134-141.
  • Vis forfatter(e) (1996). Serum house dust mite antibodies: Predictor of increased bronchial responsiveness in adults of a community. European Respiratory Journal. 919-925.
  • Vis forfatter(e) (1996). Serum house dust mite antibodies: Predictor of increased bronchial responsiveness in adults of a community. European Respiratory Journal. 919-925.
  • Vis forfatter(e) (1996). Associations of forced expiratory volume in one second to serum total IgE and respiratory virus antibodies in subexamples of a general population. American Journal of Epidemiology. 134-141.
  • Vis forfatter(e) (1995). Total serum IgE and FEV%b by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clinical and Experimental Allergy. 582-689.
  • Vis forfatter(e) (1995). Total serum IgE and FEV%b by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clinical and Experimental Allergy. 682-689.
  • Vis forfatter(e) (1995). Serum House-Dust-Mite Antibodies and Reduced FEV%b in adults of a Norwegian community. American Journal of Respiratory and Critical Care Medicine. 1158-1163.
  • Vis forfatter(e) (1995). Serum House-Dust-Mite Antibodies and Reduced FEV%b in adults of a Norwegian community. American Journal of Respiratory and Critical Care Medicine. 1158-1163.
  • Vis forfatter(e) (1995). Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. International Journal of Epidemiology. 223-231.
  • Vis forfatter(e) (1995). Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. International Journal of Epidemiology. 223-231.
  • Vis forfatter(e) (1995). Husstøvmidd sensibilisering: gir det nedsatt lungefunksjon og økt bronkial aktivitet hos voksne? Allergologen. 16-23.
  • Vis forfatter(e) (1994). Total and specific serum IgE levels in adults: relationship to sex, age and environemental factors. Clinical and Experimental Allergy. 530-539.
  • Vis forfatter(e) (1994). Total and specific immunoglobulin E-levels in a general adult population. Relationship to sex, age and environmental factors. Clinical and Experimental Allergy. 530-539.
  • Vis forfatter(e) (1993). Obstruktive lungesykdommer hos voksne. Forekomst og årsaksfaktorer. Norsk Epidemiologi. 8-11.
  • Vis forfatter(e) (1993). Obstruktive lungesykdommer hos voksne. Forekomst og årsaksfaktorer. Norsk Epidemiologi. 8-11.
  • Vis forfatter(e) (1993). Association of airflow impairment to level of serum IgE and number of respiratory virus antibodies in subsamples of a general population. The European respiratory journal. Supplement. 393-393.
  • Vis forfatter(e) (1992). Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. Thorax. 167-173.
  • Vis forfatter(e) (1992). Occupational airborne exposure of the general population of a Norwegian county. Scandinavian Journal of Work, Environment and Health. 44-51.
  • Vis forfatter(e) (1992). Non-specific challenge test for the diagnosis of asthma in a general population sample. European Respiratory Journal. 644-644.
  • Vis forfatter(e) (1992). Astmatiske lungesykdommer. Astma- og allerginytt. 3435-3435.
  • Vis forfatter(e) (1992). Allergiske sykdommer i Norge. Operative definisjoner, forekomst og risikofaktorer. Nord Med. 108-109.
  • Vis forfatter(e) (1991). Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax. 863-870.
  • Vis forfatter(e) (1991). Occupational airborn exposure and respiratory disorders in a general population of Norway. European Respiratory Journal. 273-278.
  • Vis forfatter(e) (1991). Measurements of respiration symptoms and sample size to detect a given difference between treatment groups in obstructive lung disease. European Respiratory Review. 436-443.
  • Vis forfatter(e) (1991). Bronchial responsiveness in a Norwegian community. American Review of Respiratory Diseases. 317-322.
  • Vis forfatter(e) (1990). Smoking habits and lifetime occupational exposure to gases or dusts, including asbestos and quartz, in a Norwegian community. Scandinavian Journal of Work, Environment and Health. 195-202.
  • Vis forfatter(e) (1990). Postal survey on airborne occupational exposure and respiratory disorders in Norway. Causes and consequences of non-response. Journal of Epidemiology and Community Health. 316-320.
  • Vis forfatter(e) (1990). Hayfever, eczema and urticaria in south-west Norway. Lifetime prevalences and association with sex, age, occupational airborne exposures and respiratory symptoms. Allergy. European Journal of Allergy and Clinical Immunology. 515-522.
Vitenskapelig foredrag
  • Vis forfatter(e) (2017). Repeated desaturation in 6 minute walk test increases risk for mortality in COPD patients.
  • Vis forfatter(e) (2008). Cognitive behavioural therapy (CBT) for anxiety and depression in COPD: A treatment option in pulmonary care.
  • Vis forfatter(e) (2007). Virale pneumonier hos eldre.
  • Vis forfatter(e) (2007). Cognitive behavioral therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease.
  • Vis forfatter(e) (2004). Indoor air pollutions and respiratory symptoms in a Norwegian community sample.
  • Vis forfatter(e) (2003). The association between indoor climate and respiratory symptoms in a general population sample.
  • Vis forfatter(e) (2002). Prevalence and seveity of GOLD defined COPD in adults.
  • Vis forfatter(e) (2002). Long term changes in self-reported symptoms and diagnoses of obstructive lung disease and heart disease in Oslo, Norway.
  • Vis forfatter(e) (1999). The risks of snoring and day-time hypersomnolence in a general Norwegian population. Poster.
Sammendrag/abstract
  • Vis forfatter(e) (2020). Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD. European Respiratory Journal.
  • Vis forfatter(e) (2020). Changes in the induced sputum proteome during COPD exacerbations. European Respiratory Journal.
  • Vis forfatter(e) (2019). Repeated bronchoscopy examination of the airway microbiome. European Respiratory Journal.
  • Vis forfatter(e) (2019). Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels. European Respiratory Journal.
  • Vis forfatter(e) (2017). Static hyperinflation and decline in functional capacity in COPD patients. European Respiratory Journal.
  • Vis forfatter(e) (2016). Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD. European Respiratory Journal.
  • Vis forfatter(e) (2014). Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. European Respiratory Journal.
  • Vis forfatter(e) (2012). Hu antibodies are present in smokers with chronic obstructive pulmonary disease without cancer or neurological disease. Journal of Neuroimmunology. 21-22.
  • Vis forfatter(e) (2010). Testing for Weak Signal. Genetic Epidemiology. 938-939.
  • Vis forfatter(e) (2009). How expensive is comorbidity in COPD? Respiratory Medicine. S7-S7.
  • Vis forfatter(e) (2008). Group cognitive behavioural therapy for anxiety, depression and sleep disturbances in patients with chronic respiratory illness. International Journal of Psychology (IJP). 16-16.
  • Vis forfatter(e) (2007). Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. Journal of Thoracic Oncology. S431-S431.
  • Vis forfatter(e) (2007). Cognitive behavioural therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease. Journal of Psychosomatic Research. 323-323.
  • Vis forfatter(e) (2004). Chronic airway symptoms and lung function among women in a rural community in Guatemala with high indoor air pollution levels. Epidemiology. S79-S80.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2018). Large-scale label-free quantitative mapping of the sputum proteome. Journal of Proteome Research. 2072-2091.
  • Vis forfatter(e) (2016). Participation in research bronchoscopy: a literature review. European Clinical Respiratory Journal.
  • Vis forfatter(e) (2016). Complications and discomfort of bronchoscopy: a systematic review. European Clinical Respiratory Journal. 9 sider.
  • Vis forfatter(e) (2014). Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. American Journal of Respiratory and Critical Care Medicine. 1022-1030.
  • Vis forfatter(e) (2014). Lessons from ECLIPSE: A review of COPD biomarkers. Thorax. 666-672.
  • Vis forfatter(e) (2009). Genetikk ved kronisk obstruktiv lungesykdom. Tidsskrift for Den norske legeforening. 2104-2107.
  • Vis forfatter(e) (2005). The incidence of adult asthma: a review. The International Journal of Tuberculosis and Lung Disease. 603-612.

Se fullstendig oversikt over publikasjoner i CRIStin.